Two Absolute Must-Own Stocks for the Future Money Trends Letter

Dear Reader,

Rarely do we get a chance like this to profile two of what I consider must-own stocks.

One has a 5% dividend and some of the most famous brands on the planet… In fact, I bet everyone reading this has enjoyed at least one of their products.

The other is a new player to the public markets, rapidly growing and recently announcing a new product that will incorporate cannabis.

***Including them in your portfolio of assets offers up a safe dividend (steady income), exposure to worldwide demand in all the major currencies, and the potential for accelerated growth.***

Stock Suggestion #1

I consider this to be a legacy-type stock, one that I’ve actually been waiting to purchase since 2013.

These types of plays are my personal favorite because this is one you can buy and forget about. Just allow it to compound over time, and continue to collect a dividend check for the rest of your life.

The same year I passed on the company I’m going to suggest to you now, we instead profiled another favorite of mine, Becton Dickinson (BDX), for $81.76 per share.

At the time, we referred to it as a “Forever Stock,” and I believe that is still true today. However, at its current price of $225, it’s not a good buy.

Buying quality assets is extremely important.

It’s almost as important as the price you pay, which is the most important thing, in our opinion.

Now, I can’t time any investment perfectly, as no one can. All we can do is make sure we are buying at a good price.

For the past 5 years, I’ve waited patiently to have a second opportunity to purchase shares of Anheuser Busch Inbev (NYSE: BUD).

I consider this as an important stock to be accumulated while shares are under $110.

Its fair market value per share is between $130 and $140, in our opinion.

You can also lock in that beautiful 4.57% dividend right now.

It sells more than 500 beer brands in more than 150 countries.

45% of its earnings come from Latin America, so this is an international play, with leading brands across the planet.

The most popular brands include Budweiser, Bud Light, Corona, Stella Artois, and Beck’s.

I think a monster move is coming for BUD. The current fall in its share price is from the weight of recent acquisitions. Call it an investor’s hangover, but like a real hangover, this downtrend won’t last for very long.

Consider buying shares of Anheuser Busch Inbev (NYSE: BUD). This is one of those stocks I’ll personally be buying, and I hope to never sell.

You can buy shares today for just $93.42.

Stock Suggestion #2

I love speculating in undeniable trends.

This is how I’ve made millions. It takes a tough stomach due to the nature of buying into tiny companies, however, the payoff is richly rewarding when proven right.

A massive shift is underway in the global beverage industry. Consumers are turning away from sugary sodas and energy drinks and turning to healthier alternatives.

I believe this will also include cannabis, which is a trend we definitely want to be invested in.

Our new stock suggestion is already a fast-growing player in the healthier alternative drink market, and with their major announcement recently, they’ll also be one of the first to introduce a cannabis-infused beverage.

Koios Beverage Corp. (CSE: KBEV & US: SNOVF) is a newly-listed company that is trading on the Canadian Stock Exchange.

Even though Americans can’t purchase shares on the CSE, I’ll be using its home exchange symbol when referring to it, as well as the Canadian dollar price. However, in the end, it makes no difference which exchange you buy shares on – just remember that there is a currency conversion that is reflected in the share price for each exchange.

It’s currently trading for only CAD$0.27 on the CSE and for US$0.21 on theOTC.

**The OTC symbol is on the grey markets, so many brokers will not show it or allow you to buy it until it’s on the OTCQX, OTCQB, or pink markets. We will alert you as soon as its symbol is upgraded, making it possible to purchase shares on online brokerages.***

You’re very lucky if you can buy it, in our opinion, because this stock can easily go viral, and I personally expect it to very soon.

When I spoke with a high-level scientist in the beverage industry, I was basically told that the clinical trials this company is currently running could make this an imminent takeover target because health is the largest trend in the sector, by far.

If you’re part of the 90% who can’t buy it, I’m sorry, but if you can buy it on the CSE or convince your broker to allow you to buy it on the OTC grey market, I think you may be looking at a golden goose because you’ll not only be picking up cheap shares, you’ll have a clear head start.

This is a completely undiscovered beverage play that we believe could soon become wildly popular with investors as they roll out their cannabis-infused drinks with the creation of Cannavated Beverages Co., a wholly-owned subsidiary of Koios.

The core branded drinks for Koios have nootropics, which are cognitive enhancers, natural extracts that improve memory functions, creativity, and motivation.

North America is, by far, the largest consumer of nootropics, and the growth projections are stunning.

Not surprising are the sales of Coca-Cola, who’s seeing a decline in their most popular caffeinated sugar drinks.

Koios is currently available in over 2,000 retail locations, so the upside here is perhaps greater than any company we’ve ever profiled.

It’s also potentially a future takeover for a giant, like an Anheuser Busch, PepsiCo, or Coca-Cola.

Consider buying shares of Koios Beverages (CSE: KBEV & US: SNOVF). Expect an alert from us once the OTC listing is upgraded. We expect there to be fireworks once this stock becomes available to all of North America. 
We will be covering this stock for years!

Best Regards,

Daniel Ameduri

Legal Notice: This work is based on SEC filings, current events, interviews, corporate press releases and what we’ve learned as financial journalists. It may contain errors and you shouldn’t make any investment decision based solely on what you read here. It’s your money and your responsibility. The information herein is not intended to be personal legal or investment advice and may not be appropriate or applicable for all readers. If personal advice is needed, the services of a qualified legal, investment or tax professional should be sought.

Never base any decision off of our emails. stock profiles are intended to be stock ideas, NOT recommendations. The ideas we present are high risk and you can lose your entire investment, we are not stock pickers, market timers, investment advisers, and you should not base any investment decision off our website, emails, videos, or anything we publish.  Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. Information contained in this profile was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. Never base any investment decision from information contained in our website or emails or any or our publications. Our report is not intended to be, nor should it be construed as an offer to buy or sell, or a solicitation of an offer to buy or sell securities, or as a recommendation to purchase anything. This publication may provide the addresses or contain hyperlinks to websites; we disclaim any responsibility for the content of any such other websites. We have entered into an agreement for three hundred thousand dollars and five hundred thousand options paid for directly by the company. We have also purchased shares and are long the company.  Please use our site as a place to get ideas. Enjoy our videos and news analysis, but never make an investment decision off of anything we say. Please review our entire disclaimer at